Ara Dikranian, MD
Rheumatologist
Cabrillo Center
San Diego, CA, United States
Disclosure information not submitted.
This lightning session is an overview of Janus Kinases (JAK) mechanism of action. The discussion will start with the discovery and history of JAKs. Next, we will illustrate how they interact as heterodimers (in pairs) with type I and II cytokines and regulate the downstream effects in gene transcription in the immune pathway of autoimmune disease.
The title, session, speaker, and description are subject to change.
Developed and offered by Pfizer
PP-XEL-USA-8191 ©2022 Pfizer Inc. All Rights Reserved. August 2022
